Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what assessment his Department has made of the potential benefits for people with long-term conditions such as cystic fibrosis of implementing the recommendations of the accelerated access review; and if he will make a statement.

The Government and partners published the response to the Accelerated Access Review on 3 November which outlines plans for implementation. Since the Accelerated Access Collaborative has not yet selected any products, we have not made any assessment of the benefits for any particular condition. The Accelerated Access Pathway will be operational from April 2018 when it will begin selecting products.